Pure Global AI
ANVISA registration 10339840327Valid until Sep 05, 2036

ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV)

ANVISA Registration Number: 10339840327DIASORIN LTDADIASORIN ITALIA S.P.A. UK BRANCHRisk Class IV
Device names
Technical name
ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV)
PT: ANTÍGENO E ANTICORPO DO VÍRUS DA IMUNODEFICIÊNCIA HUMANA ADQUIRIDA TIPO 1, TIPO 2 E TIPO 1 SUBGRUPO O (HIV)
Commercial name
Murex HIV Ag/Ab Combination
Risk class
Class IV
Registration details
Registration Number
10339840327
Process Number
25351219977201128
CNPJ
01896764000170
Company information
Registration Holder
DIASORIN LTDA
Manufacturing Country
United Kingdom
PT: REINO UNIDO
Dates and status
Publication Date
Sep 05, 2011
Validity
05/09/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10339840327 and manufactured by DIASORIN ITALIA S.P.A. UK BRANCH. The registration is held by DIASORIN LTDA with validity until Sep 05, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.